An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana
<p>Abstract</p> <p>Background</p> <p>The findings of the CAPRISA tenofovir studies have raised expectations that soon an approved microbicide would be available. However it is in only a limited number of countries in sub-Saharan Africa that the acceptability of microbic...
Main Authors: | Abdulai Martha A, Baiden Frank, Adjei George, Afari-Asiedu Samuel, Adjei Kwame, Tawiah Charlotte, Newton Sam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6874/12/40 |
Similar Items
-
Vaginal microbicides: An overview
by: Hany Abdel-Aleem
Published: (2011-03-01) -
Microbicides for topical immunoprevention of HIV infection
by: Yu. V. Zhernov, et al.
Published: (2019-05-01) -
Nanotechnology applications to HIV vaccines and microbicides
by: Sandhya Boyapalle, et al.
Published: (2012-01-01) -
Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
by: Pirrone Vanessa, et al.
Published: (2012-01-01) -
Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes
by: Notario-Pérez F, et al.
Published: (2017-06-01)